医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Non-anatomical liver resection for hepatocellular carcinoma:the SegSubTe classification to overcome the problem of heterogeneity

摘要Background:The superiority of anatomical resection (AR) vs. non-anatomical resection (NAR) in the surgi-cal management of hepatocellular carcinoma (HCC) is debated. ARs are well-defined procedures,whereas the lack of NAR standardization results in heterogeneous outcomes. This study aimed to introduce the SegSubTe classification for NAR detailing the appropriateness of the level of surgical section of the Glis-sonean pedicles feeding the tumor.Methods:A single-center retrospective analysis of pre-and postoperative imaging of consecutive patients treated with NAR for single HCC between 2012 and 2020 was conducted. The quality of surgery was assessed classifying the type of vascular supply and the level of surgical section (segmental,subsegmental or terminal next to the tumor) of vascular pedicles feeding the HCCs;then,the population was divided in "SegSubTe-IN" or "SegSubTe-OUT" groups,and the tumor recurrence and survival were analyzed.Results:Ninety-seven patients who underwent NAR were included;76% were SegSubTe-IN and 24% were SegSubTe-OUT. Total disease recurrence,local recurrence and cut-edge recurrence in the SegSubTe-IN vs. SegSubTe-OUT groups were 50% vs. 83% ( P=0.006),20% vs. 52% ( P=0.003) and 16% vs. 39% ( P=0.020),respectively. SegSubTe-OUT odds ratio for local recurrence was 4.1 at univariate regression analysis. One-,three-,and five-year disease-free survival rates in the SegSubTe-IN vs. SegSubTe-OUT groups were 81%,58% and 35% vs. 46%,21% and 11%,respectively ( P<0.001). Conclusions:The SegSubTe classification is a useful tool to stratify and standardize NAR for HCC,aiming at improving long-term oncological outcomes and reducing the heterogeneity of quality of NAR for HCC.

更多
广告
提交
  • 浏览0
  • 下载0
国际肝胆胰疾病杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new智医 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷